MODULE 6 MEDICATIONS Flashcards
ACTIVATED CHARCOAL
CLASSIFICATION
- ANTIDOTE
- ADSORBANT AGENT
ACTIVATED CHARCOAL
DOSE
- 25 - 50 G PO/NG
ACTIVATED CHARCOAL
INDICATION
- SUSPECTED OVERDOSE
ACTIVATED CHARCOAL
CONTRAINDICATION
- NO GAG REFLEX
- TCA OVERDOSE
- CAUSTIC SUBSTANCES
ACTIVATED CHARCOAL
ADVERSE EFFECTS
- CONSTIPATION
- ASPIRATION
- DIARRHEA
- NAUSEA
- VOMITTING
ETOMIDATE
CLASSIFICATION
- SEDATIVE HYPNOTIC
ETOMIDATE
DOSE
- 0.3 MG/KG IV/IO OVER 30
ETOMIDATE
INDICATION
- RSI
- SEDATION
ETOMIDATE
CONTRAINDICATION
- HYPERSENSITIVITY
ETOMIDATE
ADVERSE EFFECTS
- RESPIRATORY DEPRESSION
- PAIN UPON INJECTION
- LOCK JAW
- NAUSEA
- VOMITTING
KETAMINE
CLASSIFICATION
- NON-BARBITUATE ANESTHETIC (DISSOCIATIVE)
KETAMINE
DOSAGE (RSI)
- 1 - 2 MG/KG IV/IO
- 3 - 4 MG/KG IM
KETAMINE
DOSAGE (PAIN MANAGMENT)
- 5 - 20 MG IV
- 25 - 50 MG IM
- 20 - 40 MG IN
KETAMINE
DOSAGE (PEDIATRIC)
- 0.05 - 0.2 MG/KG IV
- 0.25 - 0.75 MG/KG IM
- 0.2 - 0.4 MG/KG IN
KETAMINE
INDICATION
- RSI
- EXCITED DELIERIUM
- PAIN MANAGMENT
- DISLOCATION REDUCTION
KETAMINE
CONTRAINDICATION
- LESS THAN 3 MONTHS OF AGE
- SCHIZOPHRENIC EPISODES
- PREGNANCY
KETAMINE
ADVERSE EFFECTS
- INCREASED ICP
- EXTRAPYRAMIDAL SYMPTOMS
- RASH
- NEASEA
- VOMITTING
- DROWINESS
- BRONCHIAL SECREATIONS
- CATECOLAMINE RELEASE
SUCCINYLCHOLINE
CLASSIFICATION
- NEUROMUSCULAR BLOCKING AGENT
SUCCINYLCHOLINE
DOSE
1-2 MG/KG IV/IO
(PEDI & ADULT)
SUCCINYLCHOLINE
INDICATION
- RSI
SUCCINYLCHOLINE
CONTRAINDICATION
- CONDITIONS THAT MAY CAUSE HYPERKALEMIA
- NEUOMUSCULAR DISEASE
- RENAL FAILURE
- INABILITY TO BVM
- RHABDOMYOLITIS
- MALIGNANT HYPRETHERMIA
SUCCINYLCHOLINE
ADVERSE EFFECTS
- BRADYCARDIA
- PRESSOR RESPONSE
TRANEXAMIC ACID (TXA)
CLASSIFICATION
- ANTI-FIBROLYTIC
TRANEXAMIC ACID (TXA)
DOSE
- 1-2 G IN 100 CC NS OVER 10
TRANEXAMIC ACID (TXA)
INDICATION
- TRAUMATIC HEMMORAGIC SHOCK
TRANEXAMIC ACID (TXA)
CONTRAINDICATION
- SIGNIFIGANT CLOSED HEAD INJURY
TRANEXAMIC ACID (TXA)
ADVERSE EFFECTS
- VISUAL DISTURBANCES
- DVT
- THROMBOSIS
- NEASUA
- VOMITING
- DIARRHEA
VERCURONIUM
CLASSIFICATION
- NEUROMUSCULAR BLOCKING AGENT
VERCURONIUM
DOSE
0.15 MG/KG IV/IO (INITIAL PARALYIS)
0.05 - 0.1 MG/KG IV/IO
VERCURONIUM
INDICATION
VERCURONIUM
CONTRAINDICATION
VERCURONIUM
ADVERSE REACTION